FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

102 letters match. Newest first.

  1. Umicore Argentina S.A.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  2. Nanjing Hanxin Pharmaceutical Technology Co. Ltd.

    FDA warns Nanjing Hanxin of drug-ingredient quality failures and poor supplier oversight; its drugs face U.S. import detention.

    High risk
  3. Chongqing Qiancan Technology Co., Ltd.

    Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.

    High risk
  4. Tianjin Healthcare Medical Technology Co., Ltd.

    Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.

    High risk
  5. John & Nicole Santos Dairy

    John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.

    High risk
  6. Graceful Touch, LLC

    Graceful Touch marketed 'Herpes B Gone' cream as an unapproved new drug for herpes and STI symptoms, FDA says.

    High risk
  7. Curia New York, Inc.

    FDA warned Curia New York's Rensselaer, New York API plant that undocumented lab injections, shredded records and shared passwords violate CGMP.

    High risk
  8. Kellin Chemicals Co., Ltd. - Zhangjiagang

    Kellin Chemicals' API site refused FDA inspection, so FDA calls its drugs adulterated.

    High risk
  9. Shoolin Pharma Chem LLP

    Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.

    High risk
  10. Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.

    Tianjin Kilo Pharmaceutical Sci-tech, a drug ingredient maker, cited for quality failures and missing listings for demecarium bromide and chlorambucil.

    High risk
  11. Almon Healthcare Private Limited

    Almon Healthcare, an Indian active pharmaceutical ingredient (API) maker, knowingly used mislabeled, untested raw material and shipped affected drugs to the U.S.

    High risk
  12. BioMylz Pvt. Ltd.

    FDA found destroyed records, inadequate process and cleaning validation, missing microbial testing, and incomplete drug listings at BioMylz, an Indian OTC drug manufacturer.

    High risk
  13. Shimoga Chemicals

    FDA warns Shimoga Chemicals of manufacturing quality and data integrity failures in clomiphene citrate active ingredient.

    High risk
  14. International Medication Systems Limited

    FDA found insect larvae and heavy microbial growth in International Medication Systems' sterile filling area; its epinephrine injection lot was later recalled.

    High risk
  15. Win Woo Trading, LLC / HF Foods Group

    FDA says Win Woo Trading did not develop FSVP for imported gelatin, starches, sugars, teas, rice, beans, and beverage powders.

    Medium
  16. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  17. Indiangoods.shop

    FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.

    Medium
  18. Pharmathen International S.A.

    FDA warns Pharmathen over inadequate aseptic controls at its Greek plant making sterile drugs for the U.S.

    High risk
  19. Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

    FDA: Hubei Gedian Humanwell API plant has scratched, stained equipment and weak quality unit oversight.

    High risk
  20. Alchymars ICM SM Private Limited

    FDA found Alchymars API manufacturing had poor equipment and facility maintenance, making its APIs adulterated and prompting an import alert.

    High risk
  21. Harbin Jixianglong Biotech Co., Ltd.

    FDA warned Harbin Jixianglong Biotech over CGMP (manufacturing quality rules) failures and misbranded relabeled semaglutide API with false manufacturer labels and missing drug listings.

    High risk
  22. Great One Trading Inc.

    FDA warns Brooklyn importer Great One Trading that it had no foreign supplier verification program for the foods it imports.

    Medium
  23. Hangzhou Yiqi Biotechnology Co., Ltd

    FDA cited Hangzhou Yiqi Biotechnology, an API maker in China, for four manufacturing practice failures found in a records review.

    High risk
  24. Active Cosmetics Manufacturing Inc.

    FDA cited Active Cosmetics Manufacturing for releasing topical OTC drugs after microbial contamination without thorough investigations.

    High risk
  25. Ava Inc.

    FDA warned Ava Inc. about adulterated drugs after an inspection found data-integrity failures and hidden trial injections in its Willowbrook, Illinois lab.

    High risk
  26. Guangzhou Huli Technology Co., Ltd. dba Fantasy Face

    FDA warned Guangzhou Huli Technology (dba Fantasy Face) for selling an unapproved GLP-1 weight loss drug online.

    Medium
  27. Henan Lvyuan Pharmaceutical Co. Ltd.

    FDA warns Henan Lvyuan Pharmaceutical over CGMP failures at its API plant, including water leaks and incomplete batch records.

    High risk
  28. ImmunityBio, Inc.

    FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.

    High risk
  29. Flowchem Pharma Private Limited

    FDA warned India's Flowchem Pharma over dirty API equipment, exposed materials and untested impurities, and blocked its drug imports.

    High risk
  30. El Rey USA Meats & Seafood Inc.

    FDA found El Rey USA Meats & Seafood lacked required importer verification for shrimp and tilapia.

    High risk
  31. HTO Nevada, Inc. dba Kirkman

    HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.

    High risk
  32. Meridian Bioscience, Inc

    FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.

    High risk
  33. Chemspec Chemicals Private Limited

    FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.

    High risk
  34. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  35. Absolutely Natural

    FDA warned Absolutely Natural of Melbourne, Florida, over nonprescription drug manufacturing violations, including weak contamination investigations and component testing.

    High risk
  36. Darmerica, LLC

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded

  37. Cdymax India Pharma Private Limited

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  38. Seema International

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  39. Scientific Protein Laboratories, LLC

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  40. vapingland.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  41. Hikal Limited

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  42. Chromatography Institute of America dba Compounder’s International Analytical Laboratory

    CGMP/Finished Pharmaceutical/API/Adulterated

  43. vaping.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  44. Mentha & Allied Products Private Ltd.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  45. Yangzhou Sion Commodity Co., Ltd.

    CGMP/Finished Pharmaceutical/API/Adulterated

  46. Aspen Biopharma Labs Private Limited

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  47. vapingby.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  48. Shree Jaya Laboratories PVT. LTD.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  49. Tyche Industries Ltd

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  50. Chengdu Innovation Pharmaceutical Co., Ltd.

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated